期刊文献+

散发性乳腺癌及乳腺不典型导管增生组织BRCA1基因启动子区甲基化分析 被引量:8

Promoter methylation of BRCA1 in sporadic breast cancers and breast atypical ductal hyperplasia
在线阅读 下载PDF
导出
摘要 目的了解散发性乳腺癌及癌旁增生组织、乳腺不典型导管增生组织BRCA1基因启动子区甲基化状态,探讨其与乳腺癌发生的关系。方法采用甲基化特异性PCR(MSP)结合巢式PCR技术,研究23例散发性乳腺癌及其癌旁增生组织、6例乳腺不典型导管增生组织及5例健康成人女性外周血淋巴细胞中BRCA1基因启动子区甲基化状态。结果5例健康成人女性外周血淋巴细胞均表现BRCA1基因启动子区甲基化阴性;23例原发性乳腺癌组织中,BRCA1基因启动子区CpG岛甲基化率为65.22%(15/23);癌旁增生组织检出CpG岛甲基化者11例,甲基化率为47.83%(11/23),且均为癌组织阳性患者;6例乳腺不典型导管增生组织中,BRCA1基因启动子区CpG岛甲基化阳性者2例,甲基化率为33.33%(2/6);统计学检验结果表明,乳腺癌、癌旁增生组织之间,BRCA1基因启动子区甲基化阳性率无显著差异。结论BRCA1基因启动子区CpG岛甲基化是散发性乳腺癌发生过程中的早期事件,可能在乳腺癌发生中和乳腺增生病癌变过程中起重要生物学作用。 Purpose To understand the role of promoter methylation of BRCA1 gene in the development of sporadic breast cancers. Methods By methylation specific PCR combining with Nest-PCR, we detected promoter methylation status of BRCA1 gene in 23 samples of sporadic breast cancers and their adjacent hyperplasia tissues, 6 cases of breast atypical hyperplasia and 5 samples of peripheral lymphocytes from healthy adult women. Results We found BRCA1 promoter methylafion in 15 of sporadic breast cancer tissues (65.22%). In 23 para-tumor tissues, 11 cases (47. 8% ) showed aberrant methylation of BRCA1 gene promoter. In the 6 cases of a- typical breast hyperplasia, 2 cases( 33.3% ) showed aberrant methylation in the promoter region of BRCA1 gene, while in the 5 cases of healthy adult women's peripheral lymphocytes no methylation of BRCA1 gene was found. Conclusion The promoter methylation of BRCA1 gene is an early event in the development of breast cancer and may play an important biological role in breast carcinogenesis.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2008年第2期141-145,153,共6页 Chinese Journal of Clinical and Experimental Pathology
关键词 乳腺肿瘤 乳腺不典型导管增生 甲基化 BRCA1基因 breast neoplasms breast hyperplasia methylation gene BRCA1
  • 相关文献

参考文献26

  • 1李树玲.乳腺癌防治研究现状[J].国外医学(肿瘤学分册),1993,20(4):221-226. 被引量:28
  • 2Hall J M, Lee M K, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome let al7q21 [J]. Science, 1990, 250 (4988) : 1684 - 1689.
  • 3Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 [ J]. Science, 1994, 266(5182) :66 -71.
  • 4Holt J T, Thompson, M E, Szabo C. Growth retardation and tumour inhibition by BRCA1 [J]. Nat Genet, 1996, 12:298 - 302.
  • 5Sakorafas G H, Tsiotou A G. Genetic predisposition to breast cancer: a surgical perspective[ J ]. Br J Surg, 2000, 87 (2) : 149 - 162.
  • 6Magdinier F, Ribieras S, Lenoir G M, et al. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region [ J ]. Oncogene, 1998, 17(24) :3169 -3176.
  • 7Herman J G, Baylin B S. Gene silencing in cancer in association with promoter hypermethylation [ J ]. N Engl J Med, 2003, 349 (21) :2042 - 2054.
  • 8Bianco T, Chenevix-Trench G, Walsh D C, et al. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer [ J ]. Carcinogenesis, 2000, 21(2):147- 151.
  • 9Catteau A, Morris J R. BRCA1 methylation: a significant role in tumour development[ J] ? Semin Cancer Biol, 2002, 12 ( 5 ) :359 -371.
  • 10Esteller M, Silva J M, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors[J]. J Natl Cancer Inst, 2000, 92(7) :564 -569.

二级参考文献60

共引文献72

同被引文献181

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部